Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 16.60M | $305.0M | 14.66% | +1.23M | 2026-06-30 |
| BlackRock, Inc. | 8.55M | $157.0M | 7.55% | +720.0K | 2026-06-30 |
| Bellevue Group AG | 6.73M | $123.0M | 5.94% | +5.8K | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 6.72M | $123.0M | 5.94% | +3.57M | 2026-06-30 |
| Kynam Capital Management, LP | 6.45M | $118.0M | 5.70% | +4.11M | 2026-06-30 |
| State Street Corp | 6.12M | $112.0M | 5.41% | +1.45M | 2026-06-30 |
| Price T Rowe Associates Inc | 5.75M | $105.0M | 5.08% | +2.54M | 2026-06-30 |
| Fairmount Funds Management LLC | 5.09M | $93.0M | 4.50% | +1.18M | 2026-06-30 |
| Vanguard Capital Management LLC | 4.58M | $84.0M | 4.04% | +409.7K | 2026-06-30 |
| Deep Track Capital, LP | 3.59M | $65.0M | 3.17% | +2.20M | 2026-06-30 |
